drug fda - Search News

FDA, Drug and Compounding

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list,

The National Law Review · 49m

GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List

On February 21, 2025, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order determining that the semaglutide drug shortage has been resolved. The timing of this order was unexpected due to the ongoing litigation between FDA and the Outsourcing Facilities Association (OFA) involving tirzepatide,

FiercePharma · 5h

Compounders sue FDA again over declaring end of shortage for Novo's semaglutide

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. | Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight.

Pfizer hires ex-FDA drug chief

Hosted on MSN · 1d

Pfizer Names Former FDA Drug Chief as Top Doctor

Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.

The Hill on MSN · 1d

Pfizer hires ex-FDA drug chief as top doctor

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of

Pfizer names former FDA director as chief medical officer

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory and drug safety operations.

1d

Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

FDA approves first drug for rare lipid storage disease

An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...

1h

Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs

Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.

11h

Insight: Smokescreen: some vape firms pivot after FDA crackdown

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

23hon MSN

FDA moves to rehire medical device, food safety and other staffers fired days earlier

The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...

1d

Frozen shakes served at nursing homes recalled after being linked to numerous deaths, hospitalizations: FDA

The FDA announced that a food distributor is recalling all ReadyCare and Sysco Imperial Frozen Supplemental shakes, typically ...

1d

Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results